The nuclear medicine technique, combined with other kinds of analyses, more precisely distinguishes Alzheimer’s from other neurodegenerative diseases; the test has yet to be approved for routine use in clinical practice.
Study shows that brain activity related to auditory perception parallels heart rate, offering new perspectives for the treatment of attention and communication disorders.
Implantable devices which could improve the quality of patients’ lives – Australian-made and still under tests – were presented to the congress of BRAINN, a FAPESP-funded Research, Innovation and Dissemination Center.
Brazilian tech startup Bright Photomedicine is also testing the anti-inflammatory and neurological action of photobiomodulation.
Brazilian researchers arrived at this conclusion after conducting cardiovascular fitness tests with boys and girls aged 10-17. The results were published in Cardiology in the Young.
Study suggests that people with low levels of PDIA1 in blood plasma may be at high risk of thrombosis; this group also investigated PDIA1’s specific interactions in cancer.
Brazilian researchers combined cognitive dysfunction tests with an analysis of drug use patterns to identify patients at high risk of relapse after treatment
Device developed by Spanish researchers detects the presence of the gluten peptide most resistant to digestion in urine samples. The operation is as simple as that of a drugstore pregnancy test.
A study by Brazilian researchers in partnership with Harvard estimates the impact of five risk factors on the incidence of cancer– physical inactivity, unhealthy diet, overweight, smoking and alcohol consumption.
International research group demonstrates the involvement of singlet molecular oxygen in vasodilation, causing a sharp decline in blood pressure in severe inflammatory processes such as sepsis.
Peptide developed in Brazil is capable of binding to the blood-brain barrier that protects the central nervous system and could help create novel imaging tests to diagnose Alzheimer’s and Parkinson’s.
Violet pigment produced by microorganisms found in the environment, such as Chromobacterium violaceum, displays various biological activities.
The Center for Research in Optics and Photonics, supported by FAPESP, has developed a device for the noninvasive treatment of nonmelanoma skin cancer, the most frequent type worldwide.
A review article authored by Brazilian researchers evaluated several compounds with therapeutic potential against gastric tumors.
Novel therapy developed in Israel uses a laser-activated photosensitizing drug to attack early-stage prostate cancer, according to a presentation delivered to an international event on biophotonics supported by FAPESP.
Survey covering 163 municipalities showed that toothache, bleeding and periodontal disease affected 50.57% of respondents, a proportion considered high by specialists.
Present in the most aggressive cases of a disease known as SPTCL and accounting for 60% of all cases, these mutations make the immune system attack the organism instead of protecting it.
A long noncoding RNA protects cancer cells and increases their proliferation. The discovery could lead to treatment for drug-resistant types of melanoma.
Method developed by scientists in Brazil and Canada can prevent transmission of diseases to organ recipients.
A Brazilian study shows that, like leptin, growth hormone contributes directly to energy conservation when the body loses weight.
A project conducted by researchers in Brazil and the US investigated bacteria living in symbiosis with insects as a source for novel drugs.
By identifying signature of 16 disease-related microbial species, this international study with Brazilian participation may contribute to develop predictive tests valid for populations with different dietary cultures.
Brazilian and British scientists are testing a software tool that could lower the cost of providing care to elderly patients with depression.
Few novel drugs have been developed to treat neglected diseases in recent decades, Brazilian researchers warn.
Researchers used C. elegans as an animal model to investigate the importance of certain human genes for the treatment of schizophrenia.
